[Use of dimephosphon in patients with obliterating diseases of the vessels of lower limbs during the postoperative period].
The authors compared the course of the postoperative period in patients with obliterating diseases of the vessels in the lower extremities and concomitant diabetes mellitus who were on conventional drugs and on a new home-made drug dimephosphon. It has been established that the use of dimephosphon in a complex postoperative therapy improves the results of surgical treatment of patients with obliterating atherosclerosis of the vessels in the lower extremities and concomitant diabetes mellitus. The results are due to dimephosphon-induced activation of fibrinolysis, platelet hemostasis normalization, arrest of latent disseminated intravascular coagulation syndrome, immunocorrecting drug effect and its positive impact on hormonal homeostasis.
Malenkova
T S
TS
Neĭmark
M I
MI
Sidorenkova
N B
NB
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery*; D005260:Female; D006706:Homeostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D011182:Postoperative Care; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D009943:Organophosphorus Compounds; D014665:Vasodilator Agents; C049638:dimephosphon
Primenenie dimefosfona u bol'nykh s obliteriruiushchimi zabolevaniiami sosudov nizhnikh konechnosteĭ v posleoperatsionnom periode.